27
Participants
Start Date
July 24, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Olvi-Vec
Olvi-Vec will be administered to patient for 3 days during C1
platinum (cisplatin or carboplatin)
After completing the first cycle of treatment of Olvi-Vec (+21 days after the last dose), Platinum (Carboplatin or Cisplatin)will be administrated on D1,D2 and D3 each 21 days (dosage according to the label) from Cycle 2 until disease progression or intolerable toxicity occurred.
Etoposide
After completing the first cycle of treatment of Olvi-Vec (+21 days after the last dose), Etoposide will be administrated on D1,D2 and D3 each 21 days (dosage according to the label) from Cycle 2 until disease progression or intolerable toxicity occurred.
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
RECRUITING
Shanghai chest hospital, Shanghai
Shanghai Chest Hospital
OTHER
Zhejiang Provincial People's Hospital
OTHER
Newsoara Biopharma Co., Ltd.
INDUSTRY